Long-term group(LG, n=55) was administered medium-dose aspirin for 2 weeks after diagnosis of KD, and short-term group(SG, n=32) for 48 hours afterintravenous immunoglobulin(IVIG) admin- istration. The parameters of therapeutic...
(IgM-IVIg) for treatment of relapsing-remitting MS European Committee for Treatment and Research in Multiple Sclerosis, 2000, 2000년, pp.3S125 - Stadlbauer, D. , Schocke, M. , Dilitz, E. , Deisenhammer, F....
There is extensive evidence that immune mechanisms are involved in the pathogenesis of multiple sclerosis (MS). A potential treatment effect of IVIg in MS could be mediated by several mechanisms as...
Traditionally, intravenous immunoglobulin (IVIg) has been used as replacement therapy for patients with primary or secondary immunoglobulin deficiencies. Increasingly, IVIg is being used (in doses...
그동안 나는 7가지 약물 치료법을 시도해봤고, 여러 약물 시험, 정말 많은 스테로이드의 수를 잃었다, 그리고 IVIG의 수년간. 내가 MS Society를 진단받은 해는 이 질병과 처음으로 연결되어 있었고, 그 이후로...
risk for exacerbation. The data were compared to the PRIMS study. The baseline data were... A European wide study with IVIG after delivery in MS is in preparation to confirm our preliminary...
Objectives: ; Identify the mechanism of action of intravenous immunoglobulin. ; Describe the potential adverse effects of intravenous immunoglobulin. ; Review the appropriate monitoring during therapy with intravenous immunoglobulin. ; Explain the inter-professional team strategies for improving care coordination and communication to advance treatment with intravenous immunoglobulin and improve outcomes.
IVIG IN MIS-C , - Download as a PDF or view online for free
Intravenous immunoglobulin (IVIG) is a first-line drug prepared from human plasma for the treatment of autoimmune diseases (AIDs), especially immune thrombocytopenia (ITP). Significant differences...
Biomarkers for IVIG Sensitivity by Bioinformatics Analysis Pediatric cardiology, v.37 no.6... 0b013e32835c1122 Dominguez SR, Anderson MS (2013) Advances in the treatment of Kawasaki disease....